Aristotle University Of Thessaloniki (AUTH)
Χρήση νεότερων βιοδεικτών στην πνευμονία που σχετίζεται με τον αναπνευστήρα σε διασωληνωμένα βαρέως πάσχοντα παιδιά: συσχέτιση με την εμφάνιση και την έκβαση της νόσου
Abstract
dc:descriptionIntroduction: This is the first pilot study conducted at a national level, results of which were recently added to the international literature, contributing to the diagnostic approaches of ventilator-associated pneumonia (VAP) in intubated critically ill children admitted to the Pediatric Intensive Care Unit (PICU). The aim of this study was to de-tect newer biomarkers in the blood serum and bronchial secretions and assess their association with disease occurrence and outcome. Early VAP diagnosis remains a challenge for the clinician, due to subjective clinical criteria and the low discriminatory power of diagnostic tests.Methodology: At first, inclusion and exclusion criteria for patients in the study were determined. Next, demographic and clinical character-istics were recorded. According to the modified pediatric Clinical Pulmonary Index Score (mCPIS), patients were divided into two groups: a high suspicion of VAP and a low suspicion of VAP. Samples of blood serum and bronchial secretions were collected on days 1, 3, 6 and 12 of study enrollment. A rapid diagnostic molecular platform was used to identify respiratory pathogens and the ELISA method was used to measure biomarker levels of PTX-3, SPD, sTREM-1, IL-1β, IL-4, IL-8, PAI-1 and RAGE.Results: Among 20 patients included in the study, 12 had high VAP suspicion (mCPIS ≥ 6) with a median age of 24.5 (6-141) months and 8 had low VAP suspicion (mCPIS < 6) with a median age of 129 (28-184) months. Sixty five percent were boys and 35% had underlying disease. On day 1, IL-1β levels were significantly correlated with the duration of mechanical ventilation (r = 0.67, p < 0.01) and the ICU length of stay (r = 0.66, p < 0.02). The levels of the remaining biomarkers showed no statistically significant differences between the two patient groups (p > 0.05). The simultaneous measurement of PTX3 and SPD biomarkers in blood serum and bronchial secretions demonstrated that PTX3 was mainly distributed in the blood serum, in contrast to SPD which had almost an even distribution in both the blood serum and the bronchial secretions. Two patients of the high VAP suspicion group died: the first patient due to septic shock on the third day after study enrollment and the second patient due to cardiac arrest, 30 days after study enrollment and discharge from the PICU.Conclusions: The lack of an acceptable "gold standard" as a diagnostic tool of VAP in the PICU patients warrants further research. It is considered of paramount importance to conduct multicenter studies including the above identified newer biomarkers that focus on the diagnosis, course and outcome of VAP.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Sdougka, Maria
- Σδούγκα, Μαρία
Subjects
dc:subject × 12- Πνευμονία που σχετίζεται με τον αναπνευστήρα
- Βαρέως πάσχοντα παιδιά
- Βιοδείκτες
- Ventilator associated pneumonia
- Critically ill children
- Biomarkers
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ιατρική αυξημένης φροντίδας και Εντατική θεραπεία
- Clinical Medicine
- Medical and Health Sciences
- Critical Care and Intensive Care Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/54220